Series B Funding Volume Surges to $48B as Deal Velocity Drops to Multiyear Lows

Venture capital deployment at the Series B stage has reached $48 billion year-to-date, marking its highest aggregate volume in years. However, this dollar growth masks a sharp divergence in market access: overall transaction counts for Series B rounds have contracted significantly and are currently on track to hit a multiyear low.

The data points to extreme capital concentration. Lead investors are deploying larger checks into a smaller cohort of breakout companies, particularly within high-conviction sectors like artificial intelligence and infrastructure, while leaving the broader middle market starved for growth capital. For mid-stage startups, the hurdle rate for securing institutional lead investors has escalated substantially.

This flight to quality reflects broader LP pressure on venture firms to mitigate loss ratios in uncertain macroeconomic conditions. Rather than distributing risk across wider portfolios, funds are doubling down on early winners, driving up valuations for category leaders while compressing round counts across the ecosystem.

For European and North American founders alike, the trend underscores a structural shift in mid-stage fundraising. Completing a Series B now requires demonstrably stronger unit economics and hyper-growth metrics than in previous cycles, as funds reserve their dry powder for outsized bets.